HopeStage
Back to all studies
RecruitingNCT07022925

A wearable to track perimenopause symptoms and mood

About this titleRead the official source — NCT07022925
Observational studyAges 35–55CanadaDepression
The study in practice

Understand this study

Who could participate?

Listed age limits: 35 years to 55 years.

Listed locations
LondonSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: July 4, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
110
Sponsor
IdentifyHer Limited
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
Interview / survey / observational
Study phase
Not clearly listed
Locations
Canada
Age range
From 35 Years to 55 Years
Official registry ID
NCT07022925
Official title
Show the full official title

An Observational Virtual Trial to Investigate the Accuracy of a Wearable Device in Collecting Data Related to Perimenopausal Symptoms in Women

Recruitment & locations

Currently recruiting

London

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is IdentifyHer Limited.

Who can participate?

Listed age limits: 35 years to 55 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies